BridgeMD
Tests treatment safety and results for Hemophilia A
Official title Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
ClinicalTrials.gov ID: NCT05568719
What this study is testing
- What it's testing
- A study to learn about the long-term safety and efficacy of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B respectively, who have received treatment through prior participation in a Pfizer-sponsored clinical trial. Data collection and participant visits will be based on standard of care.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- -Only participants who received investigational giroctocogene fitelparvovec or fidanacogene eleparvovec and were enrolled in a Pfizer-sponsored study...
You likely can't join if
- -None
The study team makes the final eligibility decision.
Where it's taking place
- Rancho Cordova, California, United States
- Sacramento, California, United States
- San Francisco, California, United States
- Tampa, Florida, United States
- Madison, Mississippi, United States
- New York, New York, United States
- Philadelphia, Pennsylvania, United States
- Seattle, Washington, United States
- Camperdown, New South Wales, Australia
- Toronto, Ontario, Canada
- Seoul, South Korea
- Malmö, Sweden
- Taichung, Taiwan
- Taipei, Taiwan
- Izmir, İ̇zmir, Turkey (Türkiye)
- Adana, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rancho Cordova, California, United States; Sacramento, California, United States; San Francisco, California, United States; Tampa, Florida, United States; Madison, Mississippi, United States; New York, New York, United States and 10 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.